Earnings Call · Q2 FY2025·2025-08-08

Q2 25EPS +22.43%·Rev n/aQ1 25EPS +100.00%*·Rev n/aQ4 24EPS +47.45%·Rev n/aQ3 24EPS +18.07%·Rev n/a⚠ consensus missing

PTC THERAPEUTICS, INC. PTCT

Ellen Cavaleri — Head of Investor Relations

Matthew B. Klein — Chief Executive Officer

Eric Pauwels — Chief Business Officer

Pierre Gravier — Chief Financial Officer

−9.9%1d on move date−10.7% vs SPY3d−10.1%5d−3.3%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PTCT calls or request research access.

More PTCT calls Browse calls Request research access